Introduction: Computerized respiratory sounds (CRS) are closely related to the movement of air within the tracheobronchial tree and are promising outcome measures in patients with chronic obstructive pulmonary disease (COPD). However, CRS measurement properties have been poorly tested.
outcomes. 5 Thus, international Respiratory Societies have been stressing the need to validate instruments that can express peripheral respiratory function, assess patient's response to interventions and correlate with patient-reported outcomes. 6 Computerized respiratory sounds are a simple, objective and noninvasive outcome measure that are directly related to the movement of air within the tracheobronchial tree. 7 Therefore, changes in airway and/or alveolar mechanisms may be primarily detected by changes in the frequency/intensity of normal respiratory sounds and by the presence of adventitious respiratory sounds (ie, crackles and wheezes). 7 This theoretical potential of computerized respiratory sounds to be used as an outcome measure has been motivating research of their characteristics and measurement properties. [8] [9] [10] A recent study in stable patients with COPD has shown that respiratory sounds have adequate within-day reliability. 10 However, other measurement properties need to be studied before computerized respiratory sounds utilization can be recommended for clinical practice. 11 Between-days reliability and validity are crucial measurement properties of an outcome measure which, according to the authors' best knowledge, have never been explored in computerized respiratory sounds, hindering the interpretation of its actual usefulness to assess lung function (validity) and its repeatability during prolonged stable phases (reliability). This study aimed to evaluate the between-days reliability, criterion, construct and predictive validity of computerized respiratory sounds in patients with COPD. The authors hypothesized that computerized respiratory sounds would present (a) significant and moderate between-days reliability; (b) significant, negative and low-to-moderate correlations with lung function; (c) significant, negative and moderate correlations with patient-reported outcome measures and (d) significant ability to predict acute exacerbations of COPD up to 1 year.
| MAT ERI AL S A ND M ETH ODS

| Study design
A cross-sectional study was conducted. Reliability and validity were explored, described and interpreted following the COnsensus-based Standards for the selection of health status Measurement Instruments (COSMIN) guidelines.
11,12
| Sample size
The sample size was determined according to the COSMIN guidelines, which have established that a study with good methodological quality should enroll a minimum of 50 participants. 12 
| Participants
Outpatients with stable COPD were recruited from a central hospital between January 2016 and 2017. Inclusion criteria were diagnosis of COPD according to the Global Initiative for Chronic Obstructive Lung Disease (GOLD) criteria 1 and clinical stability for 1 month prior to the study (ie, no hospital admissions, exacerbations as defined by GOLD and changes in respiratory system medication). Patients were excluded if they had severe co-existing respiratory, neurological, cardiac, musculoskeletal or psychiatric impairments. Approvals for this study were obtained from the ethics committee of a Central Hospital (13NOV'1514:40065682) and National Data Protection Committee (8828/2016). Eligible patients were identified by clinicians and then contacted by the researchers, who explained the purpose of the study and asked about their willingness to participate. When patients agreed to participate, an appointment with the researchers was scheduled and written informed consent was obtained.
| Data collection
Participants were asked to attend to two testing sessions with a 5-7 days interval. In the first session, patients completed a questionnaire with sociodemographic (age and gender) and health-related (smoking status, exacerbations in the previous year, symptoms and impact of the disease) information. Height and weight were recorded to calculate the body mass index (BMI).
Smoking status was evaluated with a two-question survey on current and previous smoking habits. Cough and wheezing were assessed through a standardized numeric rating scale (NRS) in which the patient reported the severity of the symptoms in the previous 24 hours. The NRS is reliable (Intraclass correlation coefficient, ICC 5 0.54 to 0.86) and valid to assess symptoms in patients with respiratory diseases. 13, 14 Dyspnea was collected using the modified Medical Research Council (mMRC) dyspnea scale. 15 The patients read the 5-point mMRC scale and pointed the grade (0-4) that most closely matched his or her breathlessness. Higher scores represent more breathlessness. The mMRC has shown to be a reliable (ICC 5 0.82) 16 and valid measure of disability related with dyspnea. 17 Impact of the disease was collected with the COPD Assessment Test (CAT). The CAT is a reliable (Cronbach's a 5 0.88) and valid self-administered eight-question questionnaire, which allows the assessment of the impact of COPD on health status within only a few minutes. 18 Higher scores represent higher impact of COPD.
Then, three respiratory sounds recordings were performed with air-coupled electret microphones (C 417 PP; AKG Acoustics GmbH, Vienna, Austria) 19 following the computerized respiratory sound analysis (CORSA) guidelines for short-term acquisitions. 20 Finally, lung function was assessed with a portable spirometer (MicroLab 3535; CareFusion, Kent, UK) according to the guidelines. 21 In the second session, only respiratory sounds were recorded. Effort was made to keep all factors associated with the testing sessions consistent, specifically the time of day, location of the sessions, chest locations of the microphones and order of testing.
Additionally, participants were telephoned every 3 months, up to 1 year of their initial assessment, to gather information about the occurrence of an exacerbation. 1 
| Respiratory sound recordings
Recordings were performed simultaneously at seven anatomic locations (trachea and right and left anterior upper, lateral middle and posterior lower chest). 20 The recording system included eight air-coupled electret microphones, a multi-channel audio interface (AudioBox 1818 VSL; PreSonus, Baton Rouge, LA) and a laptop computer running LungSounds@UA interface. 22 Seven microphones, mounted in couplers made Teflon, 23 were attached on the participant's skin with double-faced adhesive tapes (Double Stick Discs; 3M Littmann, Cheshire, UK), and one microphone was placed closed to the patient to record the background noise. The analog sound signals acquired were amplified and converted to digital by the audio interface with a 24-bit resolution and a sampling rate of 44.1 kHz. Each data acquisition session lasted for 20 seconds, 24 and the recorded data were later converted to.wav format.
| Signal processing
Respiratory sound files were processed by automatic algorithms implemented in Matlab R2009a (MathWorks, Natick, Massachusetts). Data were obtained for number of crackles, occupation rate of wheezes (%Wh), median frequency (F50) and maximum intensity (Imax) per respiratory phase (ie, inspiration and expiration) and per chest location. Number of crackles per respiratory phase was calculated using the following equation:
number of crackles 5 sum of crackles per respiratory phase total number of respiratory phases (1) %Wh was calculated through the following equations:
rate of each wheeze 5 duration of wheeze in the respiratory phase total duration of the respiratory phase 3 100
%Wh5 X rate of each wheeze in the respiratory phase ð Þ
F50 and Imax were calculated following the methodology proposed by Pasterkamp et al 25 after excluding adventitious respiratory sounds in each file. F50 and Imax were analyzed within a frequency band of 300-600 Hz, as this has been indicated as the most representative frequency band for patients with respiratory diseases. 26, 27 All analyses were checked by two respiratory experts and the average respiratory sound spectra and background noise were plotted to ensure the quality of sound recordings. Background noise was closely superimposed to respiratory sound intensity at lateral chest; hence, these locations were excluded from further analyses. The average spectra of normal respiratory sounds at trachea, anterior, lateral and posterior chest can be found in the Supporting Information and a detailed description of the signal processing is provided elsewhere. 28 
| Statistical analysis
Statistical analyses were performed using IBM SPSS Statistics version 24.0 (IBM Corporation, Armonk, New York) and plots were created using GraphPad Prism version 5.01 (GraphPad Software, Inc., La Jolla, California). The level of significance was set at 0.05. Descriptive statistics were used to describe the sample. Characteristics were compared between patients at stages I-II and III-IV of airflow limitation, 1 using independent t-tests for normally distributed data (age, BMI and lung function), Mann-Whitney U-tests for ordinal data (mMRC, CAT and VAS) and Chi-squared tests for categorical data (gender, smoking status and number of exacerbations/year).
| Reliability
Within-day reliability and between-days reliability were determined. Relative and absolute reliability were calculated with the ICC and the Bland and Altman method, respectively. 29 Within-day reliability was computed using the ICC equation1, k), where k 5 3 corresponds to the three recordings performed in session 1. The Bland and Altman method assesses the agreement between two sets of measures 30 ; thus, random numbers were generated in MATLAB to delete one recording. Between-days reliability was computed using the ICC equation (Equation 1, k), where k 5 2 corresponds to the two recordings used (one from session 1 and one from session 2). Bland and Altman plots were also created to analyze the distribution of results from session 1 and 2. ICC was interpreted as excellent (>0.75), moderate-to-good (0.4-0.75) or poor (<0.4). 31 
| Validity
Criterion validity was assessed by analyzing the degree to which respiratory sounds correlated with lung function (ie, percent predicted forced expiratory volume in 1 second, FEV 1 %predicted) using Spearman's rank correlation coefficient. The strength of the correlations was interpreted as negligible (ie, 0-0.30), low (0.31-0.50), moderate (0.51-0.70), high (0.71-0.90) or very high (0.91-1). 32 Receiver operating characteristic (ROC) analysis was used to assess the ability of respiratory sounds to differentiate between patients' airflow limitation severity. The ROC analysis only allows to plot the performance of a binary classification, thus, patients classified in the GOLD criteria as I and II were labeled as mild-to-moderate airflow limitation and patients classified as III and IV were labeled as severe-tovery severe airflow limitation. The cutoff for each respiratory sound parameter was chosen as the point where the sensitivity and specificity were simultaneously maximized. Area under the curves (AUC) and the 95% confidence interval were determined. AUC was interpreted as: AUC 5 0.5 no discrimination; 0.7 AUC < 0.8 acceptable discrimination; 0.8 AUC < 0.9 excellent discrimination and AUC 0.9 outstanding discrimination. 33 Construct validity was assessed by examining the relationship between respiratory sounds, NRS, mMRC and CAT using Spearman's rank correlation coefficient.
Predictive validity up to 12 months exacerbations were explored with ROC analysis and the influence of independent predictors (ie, number of crackles, %Wh, F50 and Imax) on the time until the first exacerbation was analyzed by univariate and multivariate Cox regression analyses.
| Minimal detectable changes (MDC)
MDC were only computed for respiratory sound parameters and locations that have simultaneously shown adequate between-days reliability (significant ICC > 0.75) and validity (significant correlations with FEV 1 %predicted).
To determine the MDC, first, the standard error of measurement (SEM) was calculated using the following equation:
where SD is the standard deviation of the scores obtained from all participants and ICC is the between-days reliability coefficient. The MDC at the 95% level of confidence (MDC95) was calculated as follows:
The MDC was also expressed as a percentage (MDC%), defined as
MDC%5 MDC95=mean
ð Þ 3100 (6) where 'mean' is the mean of the scores obtained in the two testing sessions. A MDC% below 30% was considered acceptable. 34 3 | RE S ULT S
| Participants
Fifty-eight patients were contacted and invited to participate in the study. However, seven refused to participate, as they did not perceive the study as relevant (n 5 5) or had family constrains to their participation (n 5 2), and one did not complete the assessment. Therefore, 50 participants (36 males) were enrolled in the study. Participants' characteristics are summarized in Table 1 .
| Reliability
Adventitious respiratory sounds presented excellent within-day reliability (ICC 1,3 > 0.75); except at trachea in both respiratory phases (0.57 < ICC 1,3 < 0.74) and at anterior chest during expiration (0.65 < ICC 1,3 < 0.73) for the number of crackles and at anterior right chest during both phases (0.51 < ICC 1,3 < 0.68) for %Wh. F50 and Imax also presented excellent reliability, except at anterior right chest during inspiration (0.51 < ICC 1,3 < 0.73). Absolute reliability showed no systematic bias for any location and/or respiratory phase according to the Bland and Altman plots. Further information of within-day reliability is in the Supporting Information. Table 2 presents the relative between-days reliability. During inspiration, crackles and wheezes showed moderateto-good or excellent reliability (0.48 ICC 1,2 0.96; P < .05) at anterior and posterior chest. F50 and Imax showed moderate-to-good or excellent reliability (ICC 1,2 > 0.47 and ICC 1,2 0.60, respectively; P < .05), except at posterior left chest (ICC 1,2 < 0.41; P > .05). During expiration, %Wh and normal respiratory sounds were reliable at trachea and at the anterior chest (ICC 1,2 > 0.54; P < .05) and the number of crackles was only reliable at trachea (ICC 1,2 5 0.79; P < .05).
Good absolute between-days reliability with no systematic bias was found in the Bland and Altman plots for number of crackles and normal respiratory sounds. However, large limits of agreement were found at trachea for all respiratory sound parameters and for %Wh in all locations, especially during expiration. Figures 1 and 2 show the Bland-Altman plots obtained at posterior right and left chest, respectively. The remaining plots are found in the Supporting Information.
| Validity
Concerning criterion validity, significant negligible-to-moderate negative correlations (-0.53 < r s < -0.28; P < .05) between FEV 1 %predicted and adventitious respiratory sounds were found, especially for the number of crackles during inspiration. Significant correlations were also found for normal respiratory sounds, being negative for inspiratory F50 and positive for Imax, especially during inspiration. Table 3 presents the correlations between FEV 1 %predicted and computerized respiratory sounds.
AUCs of all variables analyzed ranged from 0.27 to 0.81, indicating 'no discrimination' to 'acceptable discrimination'. Higher AUCs were found for inspiratory number of crackles recorded at posterior right (AUC 5 0.78; 95% CI 5 0.51-1.00; P < .001) and left (AUC 5 0.81; 95% CI 5 0.68-0.93; P < .001) chest (Figure 3) . To differentiate between participants with mild-to-moderate from participants with severeto-very severe airflow limitation, cutoff points of 0.1 (sensitivity 5 81%; specificity 5 71%) and of 0.5 (sensitivity 5 74%; specificity 5 80%) for the mean number of crackles at posterior right and left chest, respectively, were identified. Results from the ROC analysis of all computerized respiratory sounds are shown in the Supporting Information. Concerning construct validity, significant low positive (r s < 0.48; P < .05) correlations were found between patient-reported outcome measures and computerized respiratory sounds. Values for all correlations are shown in the Supporting Information.
Concerning predictive validity, both adventitious and normal respiratory sounds showed no ability to predict exacerbations up to 1 year, with AUCs ranging from 0.00 to 0.58 (P > .05). None of the computerized respiratory sound parameters were predictors of the time until the first exacerbation (P > .05; hazard ratios between 0.95 and 1.04).
| MDC
The respiratory sounds parameters presenting adequate reliability and validity were inspiratory number of crackles at posterior right chest, inspiratory F50 at trachea and anterior left chest and expiratory Imax at anterior right chest. 
| DI S CU S S I ON
To the authors' best knowledge, this is the first study describing computerized respiratory sounds reliability and validity according to the COSMIM guidelines. The main findings indicate that respiratory sounds (a) present moderate-to-excellent within-day reliability and moderate-togood between-days reliability; (b) are valid to express lung function, especially inspiratory number of crackles at posterior chest; (c) correlate poorly with patient-reported outcome measures; (d) do not predict COPD exacerbations and (e) present high values of MDC.
Moderate-to-excellent within-day reliability was found for all respiratory sound parameters, which is in line with data previously reported (ICC 1,3 from 0.66 to 0.89). 10 Regarding to between-days reliability, slightly lower values were found. This was expected, as it is known that better reliability is achieved when repeated tests are performed within short periods of time. 35 The number of inspiratory crackles, recorded at posterior chest, and inspiratory and expiratory %Wh, recorded at anterior chest, were the most reliable parameters. It is known that COPD is characterized by changes in airflow mechanics targeting mainly the smaller airways 1 ; thus, inspiratory crackles at posterior regions have been indicated as the most common and persistent finding in these patients. 10, 36 Wheezes are also a usual characteristic of patients with bronchial obstruction. 37 In the present study, inspiratory wheezes were slightly more reliable than Values are presented as ICC 1,2 (95% confidence interval).
*P < .05.
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| expiratory wheezes, which may be explained by their genesis. Patients with COPD usually experience expiratory low frequency wheezes (also known as rhonchi) in upper airways that are generally produced by increased sputum and are easily removed by cough. 36, 38 In contrast, inspiratory wheezes are more related with severe airway obstruction, 37 which characterizes most of our sample, and thus are more difficult to change with respiratory maneuvres. Similar to what has been previously described for withinday reliability, 10 the agreement assessed with the BlandAltman method was found to be acceptable for mean number of crackles and normal respiratory sounds intensity. However, high limits of agreement were found at trachea and expiratory wheezes, possibly due to their dependence on airflow and respiratory maneuvres. Therefore, this anatomic location and respiratory sound parameter may not be suitable to use in interventions studies of patients with stable COPD.
Overall, respiratory sounds showed negligible-to-moderate correlations with FEV 1 %predicted, being the strongest correlations found for the number of crackles at posterior regions. The presence of inspiratory crackles at the posterior chest also showed to be discriminative of participants with more and less severe airflow limitation. FEV 1 mainly expresses obstruction in larger airways, 2 while COPD pathogenesis primarily targets small airways. 1 In contrast, crackles are an acoustic phenomenon that, when heard over distal lung regions, are associated with inflammation or oedema 39 of smaller airways. Thus, whilst high correlations between these outcome measures would not be expected, the significant correlations found, highlight crackles potential to indicate peripheral airway obstruction in patients with COPD. Significant and lower correlations were also found between FEV 1 %predicted and Imax at the anterior chest. Similar results have been reported 40 and might be related FIGU RE 1 Bland and Altman plots of number of crackles and wheeze occupation rate (%Wh) collected at session 1 (S1) and session 2 (S2) at posterior right and left chest. Solid lines represent the zero value, and dashed lines show the associated bias and 95% upper limit of agreement (ULA) and lower limit of agreement (LLA)
FIGU RE 2 Bland and Altman plots of median frequency (F50) and maximum intensity (Imax) collected at session 1 (S1) and session 2 (S2) at posterior right and left chest. Solid lines represent the zero value, and dashed lines show the associated bias and 95% upper limit of agreement (ULA) and lower limit of agreement (LLA) with a shift of regional ventilation from the lower-to upperlung locations as a function of the degree of hyperinflation presented in more severe COPD patients. This type of hyperinflation can be reversed with therapy 41 and inspiratory maximum intensity recorded at the anterior chest may be an adequate outcome measure to assess these changes. F50 has been the respiratory sound parameter most described as related with lung function [42] [43] [44] ; however, in this study, only poor correlations were found between F50 and FEV 1 . Different methodologies used across studies (ie, no additional maneuvers or forced expiratory maneuvers or chemical substances that cause airway obstruction during respiratory sound recordings) might explain this incongruence. Nevertheless, our results mimic those from Malmberg et al 45 where a similar protocol has been used. Therefore, protocol standardization to record respiratory sounds is needed to advance knowledge in this field. Regarding construct validity, significant and negative, although low, correlations were found between respiratory sounds and patient-reported outcome measures. Similar results have been found for FEV 1 (0.14 < r < 0.41) 5 and for respiratory sounds (0.33 < r < 0.57) 46 in previous studies and further confirms that clinical outcome measures significantly differ from the individuals' experience of the disease effects on health status and hence, should not be used isolated. 47 Respiratory sounds presented no ability to predict exacerbations up to 1 year after the baseline assessment. Although changes in the tracheobronchial tree are closely related with changes in respiratory acoustics, 48 such associations are likely to be unraveled in time periods close to exacerbations, when the beginning of the inflammatory and/or infectious process has occurred. Additionally, although COPD is mainly characterized by changes in smaller airways, COPD exacerbations are frequently triggered by upper respiratory tract infections 49 ; thus, it is reasonable that predictions of these events are better detected by changes in larger airways.
Indeed, recent studies have shown that computerized respiratory sounds, recorded at trachea, have potential to predict exacerbations in the short term (ie, 5 days ahead of medical attention); however, such predictions have been determined based on complex analysis (principal component analysis) that cannot be easily understood and applicable by clinicians in clinical practice. 50 Our results have shown that F50 and Imax recorded at upper anatomical locations are valid and reliable parameters and can be more easily determined or even perceived by clinicians during auscultation. Thus, we recommend future studies on COPD telemonitoring to explore the efficacy of these normal respiratory parameters to early detect exacerbations.
High MDC values were found for all respiratory sound parameters which might be related with patients' high intervariability, as reported in previous studies. 10 These results 
| Limitations
This study has some potential limitations that need to be discussed. Flows and/or volumes were not controlled during respiratory sounds recordings and it is known that respiratory sound acoustics depends on volume and rate of respiratory maneuvers. 48 However, this can be arguable for the purposes of this study as it has been previously demonstrated that even without airflow control, respiratory sounds present adequate reliability (ICC > 0.70) and are almost as reliable as during recordings at controlled flows. 10 Moreover, this study was designed to be as close to clinical practice as possible and, currently, equipment for airflow monitoring is expensive, little portable and requires trained professionals for its interpretation, which hinders its use in such settings. This study followed the COSMIN methodological recommendations to test the suitability of an outcome measure to be implemented in the clinical practice. The COSMIN was originally developed for health-related, patient-reported outcome measures, such as questionnaires. 11 Therefore, the application of the COSMIN as a tool for guiding methodology of studies testing clinical outcome measures can be questioned. Nonetheless, in the absence of guidelines specifically designed to conduct such studies, the COSMIN is indicated as an adequate alternative tool. 51 
| CONC LUS I ON
The number of crackles recorded at posterior locations and the normal respiratory sounds recorded at trachea and anterior regions are reliable and valid parameters to assess and monitor patients with stable COPD. Nonetheless, results from criterion and construct validity showed that computerized respiratory sounds should not be used isolated, but rather integrated with other clinical and patient reported outcome measures, as they may fill the gap of assessing small airways and contribute toward a patient's comprehensive evaluation. 
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